Effect of Intravitreal Injection of Ranibizumab on Diabetic Macular Oedema at a Tertiary Centre in West Bengal: A Prospective Study

Effect of Intravitreal Injection of Ranibizumab on Diabetic Macular Oedema at a Tertiary Centre in West Bengal: A Prospective Study

Introduction: Diabetic Retinopathy (DR) is one among the many causes of visual loss in people all over the world. Diabetic Macular Oedema (DME) is the most common among vision threatening complications of DR, with a major impact on quality of life of the patient. The intravitreal ranibizumab injecti...

Full description

Bibliographic Details
Main Authors:	Vysakh Balan, Atanu Biswas
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2023-06-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	central macular thickness diabetes mellitus diabetic retinopathy foveal thickness
Online Access:	https://jcdr.net/articles/PDF/17992/59568_CE[Ra1]_F(KR)_PF1(AG_SHU)_PFA(SS)_PB(AG_SS)_PN(SS).pdf

Similar Items

Short-term results of intravitreal ranibizumab injection in eyes with diabetic macular edema
by: Ahmed Sharaf, et al.
Published: (2015-01-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Macular Thickness- An Early Predictor of Diabetic Macular Oedema
by: Chandrika Sareddy, et al.
Published: (2022-05-01)

Topical nepafenac in the treatment of center involving diabetic macular edema
by: T P Vignesh
Published: (2019-01-01)

Morphological and functional changes in the macular area in diabetic macular edema after a single intravitreal injection of aflibercept
by: Chuan-He Zhang, et al.
Published: (2023-01-01)

Macular oedema as manifestation of diabetic retinopathy
by: Mukharram M. Bikbov, et al.
Published: (2017-10-01)

Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
by: Anđela Jukić, et al.
Published: (2022-11-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

Macular changes following cataract surgery in eyes with early diabetic retinopathy: an OCT and OCT angiography study
by: Huiping Yao, et al.
Published: (2023-11-01)

Changes in Central Macular Thickness after Uncomplicated Phacoemulsification Surgery in Diabetic and Non Diabetic Patients
by: Sezen Akkaya, et al.
Published: (2018-04-01)

Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy
by: V Kavitha, et al.
Published: (2019-01-01)

Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
by: Xing P, et al.
Published: (2023-11-01)

Evaluation of Macular Thickness Changes after Uncomplicated Phacoemulsification Surgery in Healthy Subjects and Diabetic Patients without Retinopathy by Spectral Domain OCT
by: Mikel García Gómez de Segura, et al.
Published: (2022-12-01)

Foveal and Retinal Nerve Fiber Layer Thickness in Children With a History of Retinopathy of Prematurity Treated With Bevacizumab: A Cross-sectional Study
by: Amir Eftekhari Milani, et al.
Published: (2023-10-01)

Efficacy of Aflibercept and Ranibizumab in the treatment of diabetic macular edema
by: Bing Wu, et al.
Published: (2023-08-01)

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor
by: Fatma Savur, et al.
Published: (2022-12-01)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
by: Milagros Mateos-Olivares, et al.
Published: (2021-07-01)

Accidental intralenticular injection of dexametasone intravitreal implant during the treatment of refractory diabetic macular oedema
by: M. I. Kovtun, et al.
Published: (2018-04-01)

Comparison of the effect of intravitreal injection of bevacizumab with posterior subtenon injection of triamcinolone in diffuse diabetic macular oedema
by: Rohini Grover, et al.
Published: (2011-01-01)

Normative Data for Macular Thickness and Volume for Optical Coherence Tomography in a Diabetic Population without Maculopathies
by: Carolina Arruabarrena, et al.
Published: (2023-08-01)

Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
by: James F. Young, et al.
Published: (2019-07-01)

Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema
by: I-An Lai, et al.
Published: (2017-05-01)

A quantitative evaluation of the effect of meals on macular thickness in diabetic patients with diabetic macular edema
by: Yashika Sinha, et al.
Published: (2023-01-01)

The Impacts of Baseline Retinal Volume on Visual Outcomes in the Treatment of Diabetic Macular Edema
by: Mümin Hocaoğlu, et al.
Published: (2020-03-01)

Relationship Between Risk Factors and Macular Thickness in Patients with Early Diabetic Retinopathy
by: Wei Q, et al.
Published: (2022-07-01)

Indicators of Visual Prognosis in Diabetic Macular Oedema
by: Sagnik Sen, et al.
Published: (2021-05-01)

Quantitative Assessment of Choroidal Parameters in Patients with Various Types of Diabetic Macular Oedema: A Single-Centre Cross-Sectional Analysis
by: Diana Anna Dmuchowska, et al.
Published: (2021-07-01)

Assessment of macular thickness following cataract surgery in diabetic patients
by: Apurva H Suthar
Published: (2023-09-01)

Effect of silicone oil versus gas tamponade on macular layer microstructure after pars plana vitrectomy for macula on rhegmatogenous retinal detachment
by: Abdulaziz Mohammed Al-Shehri, et al.
Published: (2024-03-01)

The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
by: Rony C. Preti, et al.

Efficacy and safety of intravitreal aflibercept therapy in diabetic macular edema
by: Ali Cihat Aslan, et al.
Published: (2019-06-01)

Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V
by: Ava Torjani, BA, et al.
Published: (2023-03-01)

Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema
by: Paola Marolo, et al.
Published: (2023-06-01)

Functional improvements of diabetic macular edema after treatment with Ranibizumab
by: Hussam O Elrashidy
Published: (2021-01-01)

EVALUATION OF DIABETIC AND NON-DIABETIC PATIENTS' MACULAR THICKNESS FOLLOWING CATARACT SURGERY. A PROSPECTIVE CASE-CONTROL STUDY.
by: Sarika Ratha, et al.
Published: (2023-12-01)

Effect of Adding Oral Calcium Dobesilate to Laser Photocoagulation on the Macular Thickness in Patients with Diabetic Macular Edema: A Randomized Clinical Trial
by: Mostafa Feghhi, et al.
Published: (2014-12-01)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

Effects of intravitreal bevacizumab injection on the clinical manifestations of nonproliferative diabetic retinopathy in patients with macular edema: a systematic review
by: Touka Banaee, et al.
Published: (2016-04-01)

Effect of 25G+pars plana vitrectomy combined with preoperative intravitreal injection of Conbercept on proliferative diabetic retinopathy
by: Jing Xia, et al.
Published: (2023-02-01)

Effect of Uncomplicated Cataract Surgery on Central Macular Thickness in Diabetic and Non-diabetic Subjects
by: Brahm Prakash Guliani, et al.
Published: (2019-10-01)